We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.01%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$93.9B
AUM Growth
+$6.32B
(+7.2%)
Cap. Flow
+$695M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,650
New
346
Increased
928
Reduced
896
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$347M |
| 2 |
Cummins
CMI
|
+$334M |
| 3 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$312M |
| 4 |
AbbVie
ABBV
|
+$285M |
| 5 |
Eaton
ETN
|
+$271M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$385M |
| 2 |
DuPont de Nemours
DD
|
+$376M |
| 3 |
GSK
GSK
|
+$357M |
| 4 |
Norfolk Southern
NSC
|
+$288M |
| 5 |
Freeport-McMoran
FCX
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.03% |
| 2 | Technology | 12.99% |
| 3 | Healthcare | 11.81% |
| 4 | Consumer Discretionary | 7.48% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Silgan Holdings
SLGN
$4.51B
| $52.9M | 0.06% |
2,003,632
-38,670
| -2% | -$1.07M |
|
377
Boston Scientific
BSX
$69.2B
| $52.7M | 0.06% |
2,975,466
-785,551
| -21% | -$14M |
|
|
SYA
378
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $52.5M | 0.06% |
2,171,590
-104,566
| -5% | -$2.55M |
|
379
Baidu
BIDU
$37.7B
| $52.4M | 0.06% |
263,353
-152,280
| -37% | -$31.2M |
|
|
BNY
380
Bank of New York Mellon
BNY
$108B
| $52.4M | 0.06% |
1,248,777
+119,926
| +11% | +$5.11M |
|
|
WSTC
381
DELISTED
West Corporation
WSTC
| $51.5M | 0.05% |
1,712,232
+178,003
| +12% | +$5.63M |
|
382
Yelp
YELP
$1.46B
| $51.2M | 0.05% |
1,189,403
-734,756
| -38% | -$34.1M |
|
383
PUT
Boeing
BA
$190B
| $51M | 0.05% |
367,900
+118,800
| +48% | +$17.3M |
|
384
Southwest Airlines
LUV
$23.9B
| $50.8M | 0.05% |
1,534,119
+59,467
| +4% | +$2.33M |
|
385
PUT
SLB Ltd
SLB
$74.1B
| $50.5M | 0.05% |
586,400
+183,100
| +45% | +$16.5M |
|
386
PUT
Bristol-Myers Squibb
BMY
$130B
| $50.3M | 0.05% |
755,200
+233,700
| +45% | +$15.4M |
|
387
KeyCorp
KEY
$24.8B
| $50.1M | 0.05% |
3,336,300
+1,958,084
| +142% | +$28.9M |
|
388
Carnival Corporation Ltd
CCL
$40.6B
| $50.1M | 0.05% |
1,013,775
+454,281
| +81% | +$21.4M |
|
|
BWP
389
DELISTED
Boardwalk Pipeline Partners
BWP
| $50.1M | 0.05% |
3,447,924
-1,768,776
| -34% | -$28.7M |
|
|
AA.PRB
390
DELISTED
Alcoa Inc
AA.PRB
| $49.6M | 0.05% |
1,255,525
+1,235,525
| +6,178% | +$55M |
|
391
CF Industries
CF
$17.9B
| $49.5M | 0.05% |
769,850
+168,490
| +28% | +$10.3M |
|
392
Encompass Health
EHC
$11B
| $49.3M | 0.05% |
1,345,989
+202,489
| +18% | +$7.22M |
|
|
VRE
393
DELISTED
Veris Residential
VRE
| $49.2M | 0.05% |
2,668,830
+71,430
| +3% | +$1.3M |
|
|
STJ
394
DELISTED
St Jude Medical
STJ
| $49.1M | 0.05% |
671,842
+536,983
| +398% | +$38.8M |
|
|
OPLN
395
Openlane
OPLN
$4.69B
| $48.7M | 0.05% |
3,440,119
-1,147,141
| -25% | -$16.4M |
|
396
PUT
Coca-Cola
KO
$374B
| $48.5M | 0.05% |
1,237,500
+226,200
| +22% | +$9.2M |
|
|
ESND
397
DELISTED
Essendant Inc.
ESND
| $48.3M | 0.05% |
1,231,631
-11,123
| -0.9% | -$450K |
|
398
PUT
Qualcomm
QCOM
$165B
| $47.9M | 0.05% |
765,400
+136,100
| +22% | +$9.29M |
|
399
Colgate-Palmolive
CL
$74.4B
| $47.8M | 0.05% |
731,235
-158,841
| -18% | -$10.8M |
|
400
Universal Insurance Holdings
UVE
$1.23B
| $47.7M | 0.05% |
1,969,207
-37,972
| -2% | -$969K |
|
Similar funds
Allianz Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Allianz Asset Management held 2,650 positions worth $93.9B, up 7.2% from $87.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Allianz Asset Management's Q2 2015 filing shows 346 new, 928 increased, 896 reduced and 297 closed positions. Its largest new stake was UBS Group: 16,594,232 shares worth $348M. The largest sale was Baxter International, an estimated $385M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- Allianz Asset Management's largest Q2 2015 buy was UBS Group: 16,594,232 shares worth $348M.
- Allianz Asset Management added most to Cummins in Q2 2015, an estimated $334M increase.
- Allianz Asset Management's biggest Q2 2015 reduction was Baxter International, cutting an estimated $385M.
- Allianz Asset Management fully exited GSK in Q2 2015, selling an estimated $357M.
- Allianz Asset Management's ten largest holdings make up 12% of its $93.9B portfolio in Q2 2015.
- Allianz Asset Management opened 346 new positions and closed 297 in Q2 2015.
- Allianz Asset Management's portfolio value rose 7.2% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.